Bone mass in rett syndrome: Association with clinical parameters and MECP2 mutations

Pediatric Research

Volumn 68, Issue 5, 2010, Pages 446-451

  Shapiro, Jay R ^a   Bibat, Genila ^a   Hiremath, Girish ^a   Blue, Mary E ^a   Hundalani, Shilpa ^a   Yablonski, Theodore ^a   Kantipuly, Aditi ^a   Rohde, Charles ^b   Johnston, Michael ^a   Naidu, Sakkubai ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; METHYL CPG BINDING PROTEIN 2; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; BONE MASS; BONE MINERAL; CHILD; DISEASE SEVERITY; EXON; FEMALE; FRACTURE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC CORRELATION; HUMAN; HUMAN CELL; INFANT; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RETT SYNDROME; SCHOOL CHILD; SCOLIOSIS;

ADOLESCENT; ADULT; ANIMALS; BONE DENSITY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, KNOCKOUT; MUTATION; RETT SYNDROME; YOUNG ADULT;

EID: 77958495173     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181f2edd2     Document Type: Article

References (31)

1. Kozinetz CA, Skender ML, MacNaughton N, Almes MJ, Schultz RJ, Percy AK, Glaze DG 1993 Epidemiology of Rett syndrome: a population-based registry. Pediatrics 91:445-450
2. Bird A 2008 The methyl-CpG binding protein MeCP2 and neurological disease. Biochem Soc Trans 36:575-583
3. RettBASE IRSF MECP2 Variation Database. Available at: http://mecp2.chw.edu.au. Accessed June 9, 2010
4. Guy J, Hendrich B, Holmes M, Martin JE, Bird A 2001 A mouse MeCP2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27:322-326
5. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY 1999 Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23:185-188
6. Hagberg B, Hanefeld F, Percy A, Skjeldal O 2002 An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden, Germany, 11 September 2001. Eur J Pediatr Neurol 6:293-297
7. Trevathan E, Naidu S 1988 The clinical recognition and differential diagnosis of Rett syndrome. J Child Neurol 3:S6-S16
8. Leonard H, Thomson M, Bower C, Fyfe S, Constantinou J 1995 Skeletal abnormalities in Rett syndrome: increasing evidence for dysmorphogenetic defects. Am J Med Genet 58:282-285
9. Hoffbuhr KC, Moses LM, Jerdonek MA, Sirianni N, Scacheri C, Giron J, Schuette J, Innis J, Marino M, Philippart M, Narayanan V, Umansky R, Kronn D, Hoffman EP, Naidu S 2002 Associations between MeCP2 mutations, X-chromosome inacti-vation, and phenotype. Ment Retard Dev Disabil Res Rev 8:99-105
10. Baim S, Leonard M, Bianchi ML, Hans DB, Kalkwarf H, Langman C, Rauch F 2008 Official positions of the international Society for clinical Densitometry and Executive summary of the 2008 ISCD Pediatric Position Development Conference. J Clin Densitom 11:6-21 (Pubitemid 351602184)
11. Kalkwarf HJ, Zemel BS, Gilsanz V, Lappe JM, Horlick M, Oberfield S, Mahboubi S, Fan B, Frederick MM, Winer K, Shepherd JA 2007 The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab 92:2087-2099
12. Schwartzman F, Vitolo MR, Schwartzman JS, Morais MB 2008 [Eating practices, nutritional status and constipation in patients with Rett syndrome]. Arq Gastroen-terol 45:284-289
13. Tan KJ, Moe MM, Vaithinathan R, Wong HK 2009 Curve progression in idiopathic scoliosis: follow-up study to skeletal maturity. Spine 34:697-700
14. Chou IJ, Lin KL, Wang HS, Wang CJ 2007 Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy. Acta Paediatr Taiwan 48:317-322
15. Leonard H, Thomson M, Glasson E, Fyfe S, Leonard S, Ellaway C, Christodoulou J, Bower C 1999 Metacarpophalangeal pattern profile and bone age in Rett syndrome: further radiological clues to the diagnosis. Am J Med Genet 83:88-95
16. Haas RH, Dixon SD, Sartoris DJ, Hennessy MJ 1997 Osteopenia in Rett syndrome. J Pediatr 131:771-774
17. Motil KJ, Ellis KJ, Barrish JO, Caeg E, Glaze DG 2008 Bone mineral content and bone mineral density are lower in older than in younger females with Rett syndrome. Pediatr Res 64:435-439
18. Loder RT, Lee CL, Richards BS 1989 Orthopedic aspects of Rett syndrome: a multicenter review. J Pediatr Orthop 9:557-562
19. Downs J, Bebbington A, Woodhead H, Jacoby P, Jian L, Jefferson A, Leonard H 2008 Early determinants of fractures in Rett syndrome. Pediatrics 121:540-546
20. Ager S, Fyfe S, Christodoulou J, Jacoby P, Schmitt L, Leonard H 2006 Predictors of Scoliosis in Rett Syndrome. J Child Neurol 21:809-813
21. Lee WT, Cheung CS, Tse YK, Guo X, Qin L, Lam TP, Ng BK, Cheng JC 2005 Association of osteopenia with curve severity in adolescent idiopathic scoliosis: a study of 919 girls. Osteoporos Int 16:1924-1932
22. Gissel T, Poulson CS, Vestergaard P 2007 Adverse effects of antiepileptic drugs on bone mineral density in children. Expert Opin Drug Saf 6(3): 267-278
23. Gissel T, Poulson CS, Vestergaard P 2007 Adverse effects of epileptic drugs on bone mineral density in children. Expert Opin Drug Saf 6:267-278
24. Nettekoven S, Strohle A, Trunz B, Wolters M, Hoffmann S, Horn R, Steinert M, Brabant G, Lichtinghagen R, Welkoborsky HJ, Tuxhorn I, Hahn A 2008 Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy. Eur J Pediatr 167:1369-1377
25. Budden SS, Gunness ME 2003 Possible mechanisms of osteopenia in Rett syndrome: bone histomorphometric studies. J Child Neurol 18:698-702
26. O'Connor RD, Zayzafoon M, Farach-Carson MC, Schanen NC 2009 MeCP2 deficinecy decreases bone formation and reduces bone volume in a rodent model of Rett syndrome. Bone 45:346-356
27. Archer H, Evans J, Leonard H, Colvin L, Ravine D, Christodoulou J, Williamson S, Charman T, Bailey M, Sampson J, Klerk N, Clarke A 2007 Correlation between clinical severity in patients with Rett syndrome with a p.R168X or p.T158M MECP2 mutation, and the direction and degree of skewing of X-chromosome inactivation. J Med Genet 44:148-152
28. Allison SJ, Baldock PA, Herzog H 2007 The control of bone remodeling by neuropeptide Y receptors. Peptides 28:320-325
29. Elefteriou F 2008 Regulation of bone remodeling by the central and peripheral nervous system. Arch Biochem Biophys 473:231-236
30. Chadwick LH, Wade PA 2007 MeCP2 in Rett syndrome: transcriptional repressor or chromatin architectural protein? Curr Opin Genet Dev 17:121-125
31. Johnston MV, Blue ME, Naidu S 2005 Rett syndrome and neuronal development. J Child Neurol 20:759-763